SNOWFLAKE INC (5Q5.DE) Fundamental Analysis & Valuation

FRA:5Q5 • US8334451098

154.24 EUR
+2.08 (+1.37%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 5Q5.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall 5Q5 gets a fundamental rating of 4 out of 10. We evaluated 5Q5 against 75 industry peers in the IT Services industry. The financial health of 5Q5 is average, but there are quite some concerns on its profitability. 5Q5 shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. 5Q5.DE Profitability Analysis

1.1 Basic Checks

  • 5Q5 had positive earnings in the past year.
  • 5Q5 had a positive operating cash flow in the past year.
  • In the past 5 years 5Q5 always reported negative net income.
  • Each year in the past 5 years 5Q5 had a positive operating cash flow.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2026 0 500M -500M 1B -1B

1.2 Ratios

  • 5Q5 has a Return On Assets of -14.58%. This is amonst the worse of the industry: 5Q5 underperforms 86.67% of its industry peers.
  • With a Return On Equity value of -69.21%, 5Q5 is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.58%
ROE -69.21%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-11.9%
ROE(3y)-42.73%
ROE(5y)-31.25%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80

1.3 Margins

  • 5Q5 has a Gross Margin (67.17%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 5Q5 has grown nicely.
  • 5Q5 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y2.59%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. 5Q5.DE Health Analysis

2.1 Basic Checks

  • 5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for 5Q5 has been increased compared to 1 year ago.
  • 5Q5 has more shares outstanding than it did 5 years ago.
  • 5Q5 has a better debt/assets ratio than last year.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B

2.2 Solvency

  • The Debt to FCF ratio of 5Q5 is 2.04, which is a good value as it means it would take 5Q5, 2.04 years of fcf income to pay off all of its debts.
  • 5Q5 has a Debt to FCF ratio of 2.04. This is in the better half of the industry: 5Q5 outperforms 70.67% of its industry peers.
  • A Debt/Equity ratio of 1.18 is on the high side and indicates that 5Q5 has dependencies on debt financing.
  • 5Q5 has a Debt to Equity ratio of 1.18. This is in the lower half of the industry: 5Q5 underperforms 69.33% of its industry peers.
  • Although 5Q5's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 2.04
Altman-Z N/A
ROIC/WACCN/A
WACC8.7%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 2026 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • 5Q5 has a Current Ratio of 1.30. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
  • 5Q5 has a Current ratio (1.30) which is comparable to the rest of the industry.
  • 5Q5 has a Quick Ratio of 1.30. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
  • 5Q5 has a Quick ratio of 1.30. This is in the better half of the industry: 5Q5 outperforms 61.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. 5Q5.DE Growth Analysis

3.1 Past

  • 5Q5 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.66%, which is quite impressive.
  • Measured over the past years, 5Q5 shows a very strong growth in Earnings Per Share. The EPS has been growing by 71.45% on average per year.
  • Looking at the last year, 5Q5 shows a very strong growth in Revenue. The Revenue has grown by 29.16%.
  • 5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.23% yearly.
EPS 1Y (TTM)53.66%
EPS 3Y71.45%
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)29.16%
Revenue growth 3Y31.38%
Revenue growth 5Y51.23%
Sales Q2Q%30.12%

3.2 Future

  • 5Q5 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.82% yearly.
  • Based on estimates for the next years, 5Q5 will show a very strong growth in Revenue. The Revenue will grow by 22.46% on average per year.
EPS Next Y40.76%
EPS Next 2Y38.62%
EPS Next 3Y40%
EPS Next 5Y35.82%
Revenue Next Year26.47%
Revenue Next 2Y24.72%
Revenue Next 3Y24.82%
Revenue Next 5Y22.46%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 5B 10B 15B 20B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 5 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. 5Q5.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 5Q5 is valuated quite expensively with a Price/Earnings ratio of 142.81.
  • 74.67% of the companies in the same industry are cheaper than 5Q5, based on the Price/Earnings ratio.
  • 5Q5 is valuated expensively when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • 5Q5 is valuated quite expensively with a Price/Forward Earnings ratio of 101.24.
  • Based on the Price/Forward Earnings ratio, 5Q5 is valued a bit more expensive than 70.67% of the companies in the same industry.
  • 5Q5's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 142.81
Fwd PE 101.24
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 5Q5 indicates a slightly more expensive valuation: 5Q5 is more expensive than 72.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 55
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5Q5 does not grow enough to justify the current Price/Earnings ratio.
  • 5Q5's earnings are expected to grow with 40.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.5
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3Y40%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 5Q5.DE Dividend Analysis

5.1 Amount

  • 5Q5 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

5Q5.DE Fundamentals: All Metrics, Ratios and Statistics

SNOWFLAKE INC

FRA:5Q5 (3/11/2026, 7:00:00 PM)

154.24

+2.08 (+1.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-25
Earnings (Next)05-19
Inst Owners77.66%
Inst Owner ChangeN/A
Ins Owners2.39%
Ins Owner ChangeN/A
Market Cap52.78B
Revenue(TTM)4.68B
Net Income(TTM)-1.33B
Analysts82.46
Price Target233.5 (51.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.13%
Min EPS beat(2)10.63%
Max EPS beat(2)15.63%
EPS beat(4)4
Avg EPS beat(4)16.45%
Min EPS beat(4)10.37%
Max EPS beat(4)29.18%
EPS beat(8)7
Avg EPS beat(8)18.75%
EPS beat(12)11
Avg EPS beat(12)48.97%
EPS beat(16)14
Avg EPS beat(16)89.7%
Revenue beat(2)2
Avg Revenue beat(2)0.48%
Min Revenue beat(2)0.31%
Max Revenue beat(2)0.66%
Revenue beat(4)4
Avg Revenue beat(4)1.4%
Min Revenue beat(4)0.31%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.65%
Revenue beat(12)11
Avg Revenue beat(12)1.2%
Revenue beat(16)15
Avg Revenue beat(16)1.29%
PT rev (1m)-6.03%
PT rev (3m)-5.13%
EPS NQ rev (1m)-5.46%
EPS NQ rev (3m)-6.5%
EPS NY rev (1m)6.59%
EPS NY rev (3m)6.2%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.9%
Revenue NY rev (1m)1.73%
Revenue NY rev (3m)3.2%
Valuation
Industry RankSector Rank
PE 142.81
Fwd PE 101.24
P/S 13.12
P/FCF 55
P/OCF 50.28
P/B 31.93
P/tB 127.26
EV/EBITDA N/A
EPS(TTM)1.08
EY0.7%
EPS(NY)1.52
Fwd EY0.99%
FCF(TTM)2.8
FCFY1.82%
OCF(TTM)3.07
OCFY1.99%
SpS11.76
BVpS4.83
TBVpS1.21
PEG (NY)3.5
PEG (5Y)N/A
Graham Number10.83
Profitability
Industry RankSector Rank
ROA -14.58%
ROE -69.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.17%
FCFM 23.85%
ROA(3y)-12.99%
ROA(5y)-11.9%
ROE(3y)-42.73%
ROE(5y)-31.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.91%
GM growth 5Y2.59%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 2.04
Debt/EBITDA N/A
Cap/Depr 47.51%
Cap/Sales 2.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z N/A
F-Score6
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)56.9%
Cap/Depr(5y)99.44%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.66%
EPS 3Y71.45%
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y40.76%
EPS Next 2Y38.62%
EPS Next 3Y40%
EPS Next 5Y35.82%
Revenue 1Y (TTM)29.16%
Revenue growth 3Y31.38%
Revenue growth 5Y51.23%
Sales Q2Q%30.12%
Revenue Next Year26.47%
Revenue Next 2Y24.72%
Revenue Next 3Y24.82%
Revenue Next 5Y22.46%
EBIT growth 1Y9.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.82%
EBIT Next 3Y63.56%
EBIT Next 5Y44.67%
FCF growth 1Y26.37%
FCF growth 3Y31.1%
FCF growth 5YN/A
OCF growth 1Y27.32%
OCF growth 3Y30.83%
OCF growth 5YN/A

SNOWFLAKE INC / 5Q5.DE FAQ

What is the fundamental rating for 5Q5 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 5Q5.DE.


What is the valuation status for 5Q5 stock?

ChartMill assigns a valuation rating of 1 / 10 to SNOWFLAKE INC (5Q5.DE). This can be considered as Overvalued.


How profitable is SNOWFLAKE INC (5Q5.DE) stock?

SNOWFLAKE INC (5Q5.DE) has a profitability rating of 2 / 10.


What is the valuation of SNOWFLAKE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SNOWFLAKE INC (5Q5.DE) is 142.81 and the Price/Book (PB) ratio is 31.93.


What is the financial health of SNOWFLAKE INC (5Q5.DE) stock?

The financial health rating of SNOWFLAKE INC (5Q5.DE) is 4 / 10.